Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.

• Status: Unknown status
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

A 24 - month Study looking at the the changes in visual acuity of patients receiving PDT therapy in conjunction with intravitreal triamcinolone.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Canadian Retinal Trials Group
• Collaborators: QLT Inc.; University of British Columbia; Vancouver Hospital
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Individuals with predominantly classic, subfoveal CNV secondary to AMD.

• No previous PDT Treatment in study eye.

Exclusion Criteria:

• CNV from conditions, other than AMD.

• Other disease that could be responsible for decreased vision.